Clinical Trial Update: Maintenance Niraparib Plus Ipilimumab in Patients With Metastatic Pancreatic Adenocarcinoma Whose Disease Has Not Progressed on Platinum-Based Chemotherapy [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study evaluating maintenance Niraparib plus Ipilimumab in patients with metastatic pancreatic adenocarcinoma who …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Drugs mentioned

• Niraparib (Niraparib)
• ipilimumab (ipilimumab)

Snippet

Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: Pancreatic Adenocarcinoma Metastatic | Phase 2 | Status: RECRUITING